Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support-Reference-Cited by-同舟云学术

Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support

Published:2012-11 Issue:11 Volume:14 Page:1249-1256
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Lok Sjoukje I.¹,Winkens Bjorn²,Goldschmeding Roel³,van Geffen Ankie J.P.³,Nous Fay M.A.³,van Kuik Joyce³,van der Weide Petra³,Klöpping Corinne¹,Kirkels J. Hans¹,Lahpor Jaap R.⁴,Doevendans Pieter A.¹,de Jonge Nicolaas¹,de Weger Roel A.³

Affiliation:

1. Department of Cardiology; University Medical Centre Utrecht; Postbus 85500, 3508 GA Utrecht The Netherlands

2. Department of Methodology and Statistics; University of Maastricht; Maastricht The Netherlands

3. Department of Pathology; University Medical Centre Utrecht; Utrecht The Netherlands

4. Department of Cardiothoracic Surgery; University Medical Centre Utrecht; Utrecht The Netherlands

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1093/eurjhf/hfs120/fullpdf

Reference33 articles.

1. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics-2012;Roger;update: a report from the American Heart Association. Circulation,2012

2. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology;Dickstein;Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J,2008

3. State of the art: implantable ventricular assist devices;Lahpor;Curr Opin Organ Transplant,2009

4. Molecular changes occurring during reverse remodelling following left ventricular assist device support;Birks;J Cardiovasc Transl Res,2010

5. American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases and Emerging Risk Factors and the Stroke Council;Hlatky;Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation,2009

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth differentiation factor‐15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR program;European Journal of Heart Failure;2023-11-22

2. Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies;Molecular Aspects of Medicine;2023-10

3. CURRENT VIEWS ON THE ROLE OF GROWTH DIFFERENTIATION FACTOR 15 IN THE GENESIS, COURSE AND OUTCOME OF CARDIOVASCULAR PATHOLOGY;Complex Issues of Cardiovascular Diseases;2023-09-25

4. Myocardial Recovery DuringLVADSupport;Textbook of Transplantation and Mechanical Support for End‐Stage Heart and Lung Disease;2023-09-08

5. Growth differentiation factor-15 in patients with or at risk of heart failure but before first hospitalisation;Heart;2023-08-11